BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10442067)

  • 1. [Indications and utilization of labile blood products].
    Lapierre V; Hervé P
    Presse Med; 1999 Jul 3-10; 28(24):1321-6. PubMed ID: 10442067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mode of preparation of labile blood products--available products].
    Lapierre V; Hervé P
    Presse Med; 1999 Jul 3-10; 28(24):1314-20. PubMed ID: 10442066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An approach to prevent the severe adverse events associated with transfusion of FDA-approved blood products.
    Valeri CR; Ragno G
    Transfus Apher Sci; 2010 Jun; 42(3):223-33. PubMed ID: 20392670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriateness of transfusions of red cells, platelets and fresh frozen plasma. An audit in a tertiary care teaching hospital.
    Metz J; McGrath KM; Copperchini ML; Haeusler M; Haysom HE; Gibson PR; Millar RJ; Babarczy A; Ferris L; Grigg AP
    Med J Aust; 1995 Jun; 162(11):572-3, 576-7. PubMed ID: 7791642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood component therapy (author's transl)].
    Kretschmer V
    Anasth Intensivther Notfallmed; 1980 Jun; 15(3):189-200. PubMed ID: 7468950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood transfusions and component therapy in clinical practice].
    Korolev SS
    Med Sestra; 1981 Nov; 40(11):41-7. PubMed ID: 6915347
    [No Abstract]   [Full Text] [Related]  

  • 7. Transfusion therapy in critically ill children.
    Chang TT
    Pediatr Neonatol; 2008 Apr; 49(2):5-12. PubMed ID: 18947009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in treatment with blood and blood preparations with regard to achievements in blood preservation].
    Nowicki P
    Acta Haematol Pol; 1984; 15(3-4):213-21. PubMed ID: 6399433
    [No Abstract]   [Full Text] [Related]  

  • 9. Effective reduction of blood product use in a community teaching hospital: when less is more.
    Politsmakher A; Doddapaneni V; Seeratan R; Dosik H
    Am J Med; 2013 Oct; 126(10):894-902. PubMed ID: 24054957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of platelet and plasma transfusion on outcome in traumatic brain injury patients with moderate bleeding diatheses.
    Anglin CO; Spence JS; Warner MA; Paliotta C; Harper C; Moore C; Sarode R; Madden C; Diaz-Arrastia R
    J Neurosurg; 2013 Mar; 118(3):676-86. PubMed ID: 23259827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion in critically ill children: indications, risks, and challenges.
    Parker RI
    Crit Care Med; 2014 Mar; 42(3):675-90. PubMed ID: 24534955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical program of platelet cryopreservation.
    Schiffer CA; Aisner J; Dutcher JP; Daly PA; Wiernik PH
    Prog Clin Biol Res; 1982; 88():165-80. PubMed ID: 7100208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical use of blood, blood components and blood products.
    Blajchman MA; Shepherd FA; Perrault RA
    Can Med Assoc J; 1979 Jul; 121(1):33-42. PubMed ID: 466591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative platelet dysfunction predicts blood product transfusion in children undergoing cardiac surgery.
    Zubair MM; Bailly DK; Lantz G; Sunstrom RE; Saharan S; Boshkov LK; Sochacki P; Roger Hohimer A; Lasarev MR; Langley SM
    Interact Cardiovasc Thorac Surg; 2015 Jan; 20(1):24-30. PubMed ID: 25281704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients.
    Khan H; Belsher J; Yilmaz M; Afessa B; Winters JL; Moore SB; Hubmayr RD; Gajic O
    Chest; 2007 May; 131(5):1308-14. PubMed ID: 17400669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy.
    Anesthesiology; 1996 Mar; 84(3):732-47. PubMed ID: 8659805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks associated with the transfusion of various blood products in aortic valve replacement.
    Bjursten H; Al-Rashidi F; Dardashti A; Brondén B; Algotsson L; Ederoth P
    Ann Thorac Surg; 2013 Aug; 96(2):494-9. PubMed ID: 23816419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One year clinical audit of the use of blood and blood components at a tertiary hospital in Nigeria.
    Arewa OP
    Niger J Clin Pract; 2009 Dec; 12(4):429-33. PubMed ID: 20329686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cryopreservation at a modern blood transfusion center].
    Mempel W; Heim M; Eckstein R; Schleuning M; Horst S; Kettler H
    Fortschr Med; 1983 Nov; 101(44):2050-2. PubMed ID: 6654303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transfusions in pediatric care - common situations].
    Deschmann E; Andersson A; Frisk T; Magnusson M
    Lakartidningen; 2021 Mar; 118():. PubMed ID: 33754331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.